Welcome to our dedicated page for AUNA S.A. SEC filings (Ticker: AUNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Auna’s cross-border healthcare disclosures can feel like diagnosing without lab tests. Currency swings, prepaid plan liabilities, and oncology treatment volumes are scattered across hundreds of pages, making the company’s annual report tough to parse. If you have ever searched for “Auna insider trading Form 4 transactions” or wondered which hospital drove last quarter’s margin, you know the challenge.
Stock Titan’s platform solves that problem. Our AI reviews every Auna quarterly earnings report 10-Q filing, flags segment revenue shifts, and delivers plain-English summaries—helpful when you just need occupancy data, not accounting jargon. Real-time alerts surface Auna Form 4 insider transactions in seconds, while interactive charts turn dense 8-K material events into a clear timeline. From “Auna annual report 10-K simplified” pages that explain regional regulatory risks, to “understanding Auna SEC documents with AI” guides, we translate disclosure into insight.
Use the coverage investors rely on: track Auna executive stock transactions Form 4 before new clinic openings, compare Oncosalud growth across filings, or review the proxy statement executive compensation tables to see how bonuses align with patient volumes. Whether you need an “Auna earnings report filing analysis” or “Auna 8-K material events explained,” every document is indexed, summarized, and updated as soon as EDGAR posts. Complex filings, made clear—so you can focus on decisions, not page counts.
RWC Asset Management LLP, a UK-based investment adviser, filed Amendment No. 4 to Schedule 13G disclosing ownership of 1,523,942 ordinary shares of Auna S.A. (CUSIP L0415A103) as of 30 June 2025.
The stake equals 5.07 % of AUNA’s outstanding shares, surpassing the 5 % threshold that triggers a passive ownership filing under Section 13(d).
- Sole voting power: 1,523,942 shares
- Sole dispositive power: 1,523,942 shares
- No shared voting or dispositive power
- Reporting person classification: Investment Adviser (IA)
No intentions, transaction details, or control arrangements are disclosed. The filing simply confirms a significant but passive institutional position in Auna.
iShares BB Rated Corporate Bond ETF, a series of iShares Trust, filed its routine Form NPORT-P for the monthly period ended 30-Apr-2025.
The fund reported total assets of $286.0 million, liabilities of $81.6 million, and net assets of $204.4 million. No borrowings were outstanding and no controlled foreign corporations were used. Cash and cash equivalents not otherwise disclosed totaled $0.20 million.
Interest-rate DV01 exposure in U.S. dollars was modest, led by the 5-year bucket at $26.96 thousand; a 100-bp parallel shift (DV100) would change portfolio value by $5.17 million in the 5-year tenor. Credit-spread sensitivity shows the portfolio is predominately non-investment-grade, with a 5-year CS01 of $55.35 thousand.
The fund is active in securities lending: across 20 counterparties, securities on loan totaled roughly $38.8 million (≈19% of net assets). Largest borrowers include Barclays Bank plc (~$9.0 m), BNP Paribas Prime Brokerage (~$7.25 m) and RBC Capital Markets (~$6.30 m). The filing indicates that some counterparties provided non-cash collateral, though exact amounts were not disclosed.
No preferred stock is outstanding, and the filing does not indicate that this will be the fund’s final NPORT-P submission.